BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 184 filers reported holding BRIDGEBIO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $981 | -63.6% | 37,211 | -77.1% | 0.01% | -69.7% |
| Q1 2023 | $2,692 | +234.8% | 162,406 | +53.7% | 0.03% | +200.0% |
| Q4 2022 | $804 | -99.9% | 105,636 | +11.0% | 0.01% | +10.0% |
| Q3 2022 | $945,000 | +505.8% | 95,148 | +452.3% | 0.01% | +400.0% |
| Q2 2022 | $156,000 | -82.4% | 17,227 | -67.6% | 0.00% | -60.0% |
| Q4 2021 | $886,000 | -92.3% | 53,138 | -78.3% | 0.01% | -92.9% |
| Q3 2021 | $11,467,000 | – | 244,656 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $60,317,000 | 40.05% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $308,746,000 | 6.20% |
| M28 Capital Management LP | 513,300 | $5,102,000 | 5.33% |
| GREAT POINT PARTNERS LLC | 1,050,000 | $10,437,000 | 2.51% |
| Octagon Capital Advisors LP | 933,743 | $9,281,000 | 1.60% |
| HHLR ADVISORS, LTD. | 5,362,014 | $53,298,000 | 1.40% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $264,613,000 | 1.22% |
| Cormorant Asset Management, LP | 1,469,179 | $14,604,000 | 1.02% |
| Fernwood Investment Management, LLC | 204,550 | $2,033,000 | 0.86% |
| TANG CAPITAL MANAGEMENT LLC | 585,424 | $5,819,000 | 0.71% |